Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Misceláneo/Otras Enfermedades / Timoma / Recursos de NCI
National Cancer Institute®
Ultima Vez Modificado: 1 de junio del 2002
1
UI - 11974900
AU - Naniwa T; Kakihara H; Zen-nami S; Tomita H; Sugiura Y; Yoshinouchi T;
TI -
Sato S; Ueda R
[Recurrence of thymoma accompanied with hypogammaglobulinemia 20 years
after surgery: a case report]
SO - Nihon Kokyuki Gakkai Zasshi 2002 Mar;40(3):241-4
AD - Second Department of Internal Medicine, Nagoya City University Medical
School.
We reported a case of recurrence of localized thymoma accompanied with
hypogammaglobulinemia (Good's syndrome) 20 years after surgery. A
74-year-old man was admitted to this hospital because of mediastinal
tumor and chronic pulmonary infection. He had been thymectomised at the
age of 55 because of spindle cell thymoma. After that, he had been
productive cough, and low-grade fever. Laboratory findings revealed
hypogammaglobulinemia. Percutaneous needle biopsy of the mediastinal
tumor revealed spindle cell thymoma. Therefore, hypogammaglobulinemia
with thymoma (Good's syndrome) accompanied with a chronic lower
respiratory tract infection was diagnosed. Immunologic studies revealed
a marked decrease of CD 20 positive cells and decreased lymphocyte
activation under the stimuli of phytohemagglutinin and concanavalin A.
The thymoma was resected in Dec 1997, but the serum immunoglobulin
showed no increase at al.
2
UI - 12048910
AU - Okumura M; Ohta M; Miyoshi S; Mori T; Yasumitsu T; Nakahara K; Iuchi K;
TI -
Tada H; Maeda H; Matsuda H
Oncological significance of WHO histological thymoma classification. A
clinical study based on 286 patients.
SO - Jpn J Thorac Cardiovasc Surg 2002 May;50(5):189-94
AD - Thoracic Surgery Study Group, Division of General Thoracic Surgery,
Department of Surgery, Interventional Medicine (E-1), Osaka University
Graduate School of Medicine, 2-2 Yamadaoka, Suita-City, Osaka 565-0871,
Japan.
OBJECTIVES: The clinical significance of thymoma histology remains
controversial because of the numerous histological classifications of
thymic epithelial tumors. Universal classification of such tumors was
achieved by the World Health Organization (WHO) in 1999. We studied the
prognostic significance of this classification. METHODS: We studied
clinical features and postoperative survival in cases of thymoma, but
not thymic carcinoma, based on WHO histological classification in 286
patients undergoing surgery between 1958 and 2001. RESULTS: Tumors were
19 type A, 79 type AB, 59 type B1, 102 type B2, and 27 type B3. The
proportion of invasive tumors increased by type--from A to AB, B1, B2,
and B3. The great vessels were involved more frequently in type B2 and
B3 tumors than in type A, AB, and B1 tumors. The 20-year survival was
100% in type A, 87% in type AB, 91% in type B1, 65% in type B2, and 38%
in type B3 tumors. Multivariate analysis showed Masaoka staging and WHO
histological classification to be significant independent prognostic
factors, while age, gender, myasthenia gravis association, resection
completeness and great vessel involvement were not. In stage III
patients, 13 of 45 patients with type B2 and B3 tumor died of their
tumors, while no tumor deaths occurred in 11 patients with type A, AB,
and B1 tumors. CONCLUSION: WHO histological classification realistically
reflects the oncological behavior of thymoma.
3
UI - 11557903
AU - Forterre O; Houze JP; Picard A
TI -
[Malignant thymoma: a strange goiter]
SO - J Chir (Paris) 2001 Aug;138(4):232
AD - Service de Chirurgie Digestive, Endocrinienne et Thoracique, Centre
Hospitalier, Belfort, France.
4
UI - 12048906
AU - Sugihara M; Gomyo Y; Sumii K; Tadehara F; Yoshida Y
TI -
[A 42-year-old man with cardiac systolic murmur and a mediastinal tumor.
Invasive thymoma (predominantly epithelial type, clinical stage IVa)]
SO - J Cardiol 2002 May;39(5):281-3
AD - Division of Cardiology, Mazda Hospital, Aosaki, Minami 2-15, Fuchu-cho,
Akigun, Hiroshima 735-8585.
5
UI - 11170933
AU - Arend SM; Dik H; van Dissel JT
TI -
Good's syndrome: the association of thymoma and hypogammaglobulinemia.
SO - Clin Infect Dis 2001 Jan 15;32(2):323-5
6
UI - 11462204
AU - Tarr PE; Lucey DR; Infectious Complications of Immunodeficiency with
TI -
Thymoma (ICIT) Investigators
Good's syndrome: the association of thymoma with immunodeficiency.
SO - Clin Infect Dis 2001 Aug 15;33(4):585-6
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.
Dr. Rustgi discusses genomics and cancer and translating laboratory research into clinical practice. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

